BioLife Solns (NASDAQ: BLFS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of BioLife Solns (NASDAQ: BLFS) through any online brokerage.
The latest price target for BioLife Solns (NASDAQ: BLFS) was reported by Stephens & Co. on Tuesday, May 10, 2022. The analyst firm set a price target for 40.00 expecting BLFS to rise to within 12 months (a possible 168.10% upside). 4 analyst firms have reported ratings in the last year.
The stock price for BioLife Solns (NASDAQ: BLFS) is $14.92 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for BioLife Solns.
BioLife Solns’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for BioLife Solns.
BioLife Solns is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.